Immatics NV
NASDAQ:IMTX
Immatics NV
Cash from Investing Activities
Immatics NV
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Immatics NV
NASDAQ:IMTX
|
Cash from Investing Activities
-€31.4m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
BioNTech SE
NASDAQ:BNTX
|
Cash from Investing Activities
-€7B
|
CAGR 3-Years
-263%
|
CAGR 5-Years
-154%
|
CAGR 10-Years
N/A
|
|
MorphoSys AG
XETRA:MOR
|
Cash from Investing Activities
€15.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CureVac NV
NASDAQ:CVAC
|
Cash from Investing Activities
-€55.2m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-67%
|
CAGR 10-Years
N/A
|
|
Biotest AG
XETRA:BIO
|
Cash from Investing Activities
€1.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-64%
|
CAGR 10-Years
N/A
|
|
Formycon AG
XETRA:FYB
|
Cash from Investing Activities
-€37.1m
|
CAGR 3-Years
-87%
|
CAGR 5-Years
-136%
|
CAGR 10-Years
N/A
|
See Also
What is Immatics NV's Cash from Investing Activities?
Cash from Investing Activities
-31.4m
EUR
Based on the financial report for Dec 31, 2023, Immatics NV's Cash from Investing Activities amounts to -31.4m EUR.
What is Immatics NV's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-18%
Over the last year, the Cash from Investing Activities growth was 85%. The average annual Cash from Investing Activities growth rates for Immatics NV have been -25% over the past three years , -18% over the past five years .